3-[[5-Methyl-2-(1-methylethyl)cyclohexyl]oxy]propane-1,2-diol
| Common Name: |
3-[[5-Methyl-2-(1-methylethyl)cyclohexyl]oxy]propane-1,2-diol |
| IUPAC Name: |
3-(5-methyl-2-propan-2-ylcyclohexyl)oxypropane-1,2-diol |
| Molecular Formula: |
C8H14O2 |
| SMILES: |
CC1CCC(C(C1)OCC(CO)O)C(C)C |
| Inchi: |
1S/C13H26O3/c1-9(2)12-5-4-10(3)6-13(12)16-8-11(15)7-14/h9-15H,4-8H2,1-3H3 |
| Inchi Key: |
MDVYIGJINBYKOM-UHFFFAOYSA-N |
| Cas No: |
87061-04-9 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
1 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
142.20 |
| Mass (g/mol) |
230.188 |
| Molar Refractivity |
41.38 |
| Net Charge |
|
| HBD |
|
| HBA |
2 |
| Rt Bonds |
5 |
| Rings |
1 |
| TPSA |
26.30 |
| Hetero Atoms |
3 |
| Heavy Atoms |
10 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
361.00 to 362.00 |
| Vapor Pressure (mmHg@25.00 °C) |
|
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.62 |
| LogP |
1.817 |
| iLOGP |
2.19 |
| XLOGP3 |
1.89 |
| WLOGP |
1.91 |
| MLOGP |
1.85 |
| ESOL Log S |
-1.58 |
| ESOL Solubility (mg/ml) |
3.72 |
| ESOL Solubility (mol/l) |
0.026 |
| ESOL Class: esol_class |
Very soluble |
| Ali Log S |
-2.06 |
| Ali Solubility (mg/ml) |
1.22 |
| Ali Solubility (mol/l) |
0.01 |
| Ali Class |
Soluble |
| Silicos-IT LogSw |
-1.62 |
| Silicos-IT Solubility (mg/ml) |
3.4 |
| Silicos-IT Solubility (mol/l) |
0.02 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-5.83 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.522 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
1.733 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
0 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
1 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
